Healthcare providers who practice Pain Management, Occupational Medicine, Addiction Treatment, and other disciplines often use urine drug testing for monitoring of prescription and recreational drug use. In studies of chronic pain patients on opioid therapy, twenty percent of subjects were found to have an illicit substance in their urine.
The Department of Transportation does not permit any test other than UDT for detection of substances that may pose a safety risk. Additionally, hair testing has the following limitations:
Because of the sensitive nature of testing and importance of an accurate response to the patient’s employment and/or health outcome, patients may be tempted to submit a substitute or adulterated specimen in an attempt to deceive or influence test outcomes. Detection of substitutes can be difficult, until now.
Specimen validation is now as simple as a cheek swab with NextGen UDT™ with ToxProtect™ by Genotox Labs. Your patient will supply a urine specimen, and a buccal swab is collected at the same time. Specimens are cross verified to confirm that the same patient submitted both samples, helping to establish trust between provider and patient.
 Michna et al, Clin J Pain. 2007 Feb;23(2):173-9.
© Personalized Health Solutions, LLC. All rights reserved.